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1029-187 A Novel Invasive Assessment of the Coronary 
Microcirculation 
William F. Fearon, Leora B. Balsam, H. M. Omar Farouque, Anthony D. Caffarelli, 
Robbert C. Robbins, Peter J. Fitzgerald, Paul G. Yock, Alan C. Yeung, Stanford 
University, Stanford, CA 
Background: A relatively simple. invasive method for assessing the status of the coro- 
nary microcirculation independent of the epicardial artery is lacking. 
Methods: Using a coronary pressure wire and modified software, which allows the pres- 
sure transducer to act as a distal thenistor and the shaft of the wire as a proximal ther- 
mistor, it is possible to calculate the mean transit time of room temperature saline 
injected down the left anterior descending artery (LAD) during maximal hyperemia. The 
inverse of this hyperemic mean transit time has been shown to correlate with absolute 
hyperemic flow. We hypothesized that the distal coronary pressure divided by the inverse 
of the mean transit time would provide an Index of Microcirculatory Resistance (IMR) that 
would correlate with true microcirculatory resistance (distal pressure/distal flow). Using 
an open-chest pig model, we compared IMR to the true microcirculatory resistance, 
defined as the distal LAD pressure measured with the coronary pressure wire, divided by 
absolute flow, measured with an external flow probe around the LAD, at maximal hypere- 
mia. In 6 pigs these measurements were made in a normal LAD, after creation of an epi- 
cardial LAD stenosis, and after disruption of the coronary microcirculation using 
embolized microspheres, with and without an epicardial LAD stenosis. 
Results: In a total of 31 measurements, IMR correlated with true microcirculatory resis- 
tance (r=0.52, p=O.O03). The average IMR in vessels with disrupted microcirculation, irre- 
spective on the epicardial artery status, was 30.3 *14 versus 17.7 i5.5 in those with 
normal microcirculation (p=O.O02). The corresponding values for the true microcirculatory 
resistance were 0.93 +0.38 vsrsus 0.51 i0.23 mmHg/ml/min (pcO.001). Doppler wire- 
derived coronary flow reserve correlated weakly with true microcirculatory resistance (r=- 
0.38, p=O.O4). 
Conclusion: This Index of Microcirculatory Resistance (IMR) provides a simple, quanti- 
tative, invasive assessment of the coronary microcirculation independent of the epicar- 
dial artery. 
1029-l 88 Baseline Hemoglobin Is a Novel Predictor of Mortality 
After Percutaneous Coronary Intervention 
Anna~oorna S. Kini, Paul Lee, Cristina A. Mitre. Samin K. Sharma, The Mount Sinai 
Medical Center, New York, NY, The University of Toronto, Toronto, ON, Canada 
Background: Anemia has been reported as an important factor of adverSe prognosis in 
various patient subgroups with critical illness, hearl failure, or MI. The effect of baseline 
hemoglobin (BHb) level on acute and mid-term results in patients undergoing PCI has 
not been reported. 
Methods and Results: We analyzed 6289 consecutive PCI patients at our center from 
July 1999 to June 2002, for in-hospital events and l-year mortality. Patients were divided 
in 3 groups based on BHb: clO, lO-12, and z.12 g/dL. BHb was an independent predictor 
of LVEF along with diabetes, MI, chronic renal failure, and number of vessel diseased. 
Peri-procedural creatine kinase-MB (218 U/L) and troponin I (~2 ng/mL) elevation was 
significantly higher in the low BHb vs. normal BHb group (p=O.OOl). Even aHer adjust- 
ment for baseline characteristics, BHb level independently correlated with mortality on 
multivariate analysis (figure). Other independent predictors of mortality were: age 
(p=O.ooOl), LVEF ~30% (p=O.Oi), symptomatic heart failure (p=O.O2), peripheral vascu- 
lar disease (p=O.Ol), and pre-PCI GP Ilb/llla use (p=O.Ol). 
Conclusion - In the current PCI era, among other well-established predictors of mortal- 
ity, BHb <12 g/dL has been found to be an independent predictor of mortality. This may 
be mediated by an exacerbation of the imbalance between oxygen supply and demand 
present in patients with coronary artery disease undergoing PCI. The present analysis 
underscores the role of the stem cell function during PCI. 
1029-189 Baseline C-Reactive Protein and Cardiac Troponin I as 
Predictors of Outcome Following Percutanous 
Coronary Intervention in Stable and Unstable Coronary 
Disease 
Thuraia Naoel$ Roy A. Sherwood, Ray J. Wainwright, Ajay M. Shah, David E. Jewitt, 
Belinda Asonganyi. Martyn R. Thomas. King’s College Hospital, London, United 
Kingdom 
Background: Elevated C-reactive protein (CRP) appears to be strongly predictive of 
adverse cardiac events in stable and unstable cardiac disease. Cardiac Troponin I (cTnl) 
has also been shown to be a strong prognostic marker of outcome. We compared the 
predictive value of both markers for adverse events following percutaneous coronary 
intervention (PCI). Methods: A total of 466 (316 stable and 150 unstable) patients pre- 
senting with coronay disease suitable for PCI were studied prospectively. Baseline CRP 
and cTnl concentrations were determined pre-PCI and the patients were followed up for 
adverse cardiac events (death, Q wave Ml or repeat revascularisation) for up to 18 
months. Resulte: Baseline CRP was elevated in 11% of stable and 35% unstable 
patients (Chi2 = 44.5, p<O.OOOl). cTnl was positive in 2.5% of stable and 25% of unstable 
patients (Chi* = 43.9, pcO.0001). Amongst the stable population, 56% of CRP-positive 
patients and 25% of cTnl-positive patients had adverse events at follow up. In the unsta- 
ble patients, 57% CRP-positive and 42% cTnl-positive patients had adverse events at 
follow up. In stable patients, elevated baseline CRP had a positive predictive value (PPV) 
for adverse events of 0.6 and a negative predictive value (NPV) of 0.8 (Chi’ = 29.1, 
p<O.OOOl). Baseline cTnl was not significantly predictive of long term outcome amongst 
the stable population. In unstable patients, CRP had a PPV of 0.6 and a NPV of 0.9 (Chi’ 
= 26.9, p<O.oOOl) and cTnl a PPV of 0.6 and NPV of 0.8 (Chi* = 35.7. p<O.OOOl). The 
combination of a positive CRP and cTnl had a PPV of 0.7 and NPV of 0.8 in stable and 
unstable patients &hi2 = 60.68 and 54.4, respectively; pcO.0001). The Odds Ratio (OR) 
for adverse events at follow up increased progressively with higher quartiles of CRP: 
25th centile OR 3.8 (95% Cl 1.5 to 7.9), 50th centile OR 9.8 (95% Cl 5.2 to 16.2) and 
75th Gentile OR 11.6 (95% Cl 4.4 to 15.7). Conclusions: Elevated baseline CRP is a 
strong and independent predictor of adverse events in both stable and unstable coronary 
disease. Baseline cTnl is only useful as a prognostic marker in unstable patients. The 
combination of an elevated CRP and cTnl provided only a marginal additional benefit to 
the prognostic value of CRP alone. 
1029-l 90 Restoration of Normal Coronary Flow Afler No-Reflow 
Phenomenon Does Not Improve Post-Procedural 
Myocardial Infarction in Patients Without ST-Segment 
Elevation Myocardial Infarction 
Gem Barcin, Ali E. Denktas. Ryan J. Lennon, LaVon Hammes, Amir Lerman, David R 
Holmes, Jr., Kirk N. Garratt, Mayo Clinic, Rochester, MN 
Background: No-reflow phenomenon (NR) during percutaneous coronary intervention 
(PCI) is a strong predictor of major cardiac events in acute myocardial infarction (Ml). We 
sought to determine the effects of NR on outcome and the significance of restoration of 
flow in patients without ST segment elevation MI(STEMI). 
Methods: We evaluated 3390 PCls performed between l/2000 and 12/2001 in Mayo 
Clinic. Pts without STEMI who had an NR episode were identified and divided into 2 
groups according to final angiogram [complete restoration (TIMI 3) vs. partial restoration 
(<TIM1 3)]. TIMI flow grades were classified as TIMI 0, 1, 2 “slow”, 2 ‘?a?? and 3 and 
scored as 0, 1, 2, 2.5 and 3, respectively. Pts who had an episode of NR (n=76) were 
comoared with aae. sex and seoment matched controls without STEMI (n=152) in terms 
of in-hospital and 6-month death, MI and target vessel revascularization rates. 
Results:TIMI scores from NR eoisode to the flnal anaioaram imoroved from 1.4 * 0.8 to 
3.0 * 0.0 in the complete group (n=34) and from 1.6 * 0.7 to 2.4 * 0.3 in the partial group 
(n=42). Despite complete restoration of epicardial flow, post-procedural Ml was higher 
than the control group and was not different from partial restoration group (see table). 
Six-month outcome was similar among groups. 
Conclusion: No-reflow is associated with poor prognosis even in pts without STEMI 
despite complete restoration of epicardial coronary flow. This finding may suggest the 
discordance between the blood flow in epicardial and myocardial level. 
